216 related articles for article (PubMed ID: 23679338)
1. Complicated postoperative recovery increases omission, delay and discontinuation of adjuvant chemotherapy in patients with Stage III colon cancer.
van der Geest LG; Portielje JE; Wouters MW; Weijl NI; Tanis BC; Tollenaar RA; Struikmans H; Nortier JW;
Colorectal Dis; 2013; 15(10):e582-91. PubMed ID: 23679338
[TBL] [Abstract][Full Text] [Related]
2. Aspects of survival from colorectal cancer in Denmark.
Iversen LH
Dan Med J; 2012 Apr; 59(4):B4428. PubMed ID: 22459726
[TBL] [Abstract][Full Text] [Related]
3. Practical outcome of adjuvant FOLFOX4 chemotherapy in elderly patients with stage III colon cancer: single-center study in Korea.
Kim JY; Kim YJ; Lee KW; Lee JS; Kim DW; Kang SB; Lee HS; Jang NY; Kim JS; Kim JH
Jpn J Clin Oncol; 2013 Feb; 43(2):132-8. PubMed ID: 23204187
[TBL] [Abstract][Full Text] [Related]
4. Effect of postoperative complications on adjuvant chemotherapy use for stage III colon cancer.
Merkow RP; Bentrem DJ; Mulcahy MF; Chung JW; Abbott DE; Kmiecik TE; Stewart AK; Winchester DP; Ko CY; Bilimoria KY
Ann Surg; 2013 Dec; 258(6):847-53. PubMed ID: 24169157
[TBL] [Abstract][Full Text] [Related]
5. Timing of adjuvant chemotherapy initiation after surgery for stage III colon cancer.
Hershman D; Hall MJ; Wang X; Jacobson JS; McBride R; Grann VR; Neugut AI
Cancer; 2006 Dec; 107(11):2581-8. PubMed ID: 17078055
[TBL] [Abstract][Full Text] [Related]
6. Timing of adjuvant chemotherapy and its relation to survival among patients with stage III colon cancer.
Bos AC; van Erning FN; van Gestel YR; Creemers GJ; Punt CJ; van Oijen MG; Lemmens VE
Eur J Cancer; 2015 Nov; 51(17):2553-61. PubMed ID: 26360411
[TBL] [Abstract][Full Text] [Related]
7. Impact of race/ethnicity and socioeconomic status on adjuvant chemotherapy use among elderly patients with stage III colon cancer.
Hsieh MC; Chiu YW; Velasco C; Wu XC; O'Flarity MB; Chen VW
J Registry Manag; 2013; 40(4):180-7. PubMed ID: 24625772
[TBL] [Abstract][Full Text] [Related]
8. Adjuvant chemotherapy for colon carcinoma with positive lymph nodes: use and benefit in routine health care practice.
Bouchardy C; Queneau PE; Fioretta G; Usel M; Zellweger M; Neyroud I; Raymond L; de Wolf C; Sappino AP
Br J Cancer; 2001 Nov; 85(9):1251-7. PubMed ID: 11720457
[TBL] [Abstract][Full Text] [Related]
9. Adjuvant chemotherapy for stage III colon cancer: do physicians agree about the importance of patient age and comorbidity?
Keating NL; Landrum MB; Klabunde CN; Fletcher RH; Rogers SO; Doucette WR; Tisnado D; Clauser S; Kahn KL
J Clin Oncol; 2008 May; 26(15):2532-7. PubMed ID: 18487570
[TBL] [Abstract][Full Text] [Related]
10. Estimating the adjuvant chemotherapy effect in elderly stage II and III colon cancer patients in an observational study.
Kim KY; Cha IH; Ahn JB; Kim NK; Rha SY; Chung HC; Roh JK; Shin SJ
J Surg Oncol; 2013 May; 107(6):613-8. PubMed ID: 23592499
[TBL] [Abstract][Full Text] [Related]
11. A population-based study of adjuvant chemotherapy for stage-II and -III colon cancers.
Phelip JM; Molinié F; Delafosse P; Launoy G; Trétarre B; Bara S; Buémi A; Velten M; Danzon A; Ganry O; Bouvier AM; Grosclaude P; Faivre J
Gastroenterol Clin Biol; 2010 Feb; 34(2):144-9. PubMed ID: 20079591
[TBL] [Abstract][Full Text] [Related]
12. Treatment patterns for stage III colon cancer and factors related to receipt of postoperative chemotherapy in Louisiana.
Wu X; Chen VW; Andrews PA; Chen L; Hsieh M; Fontham ET
J La State Med Soc; 2004; 156(5):255-61. PubMed ID: 15554095
[TBL] [Abstract][Full Text] [Related]
13. Survival and time interval from surgery to start of chemotherapy among colon cancer patients.
Zeig-Owens R; Gershman ST; Knowlton R; Jacobson JS
J Registry Manag; 2009; 36(2):30-41; quiz 61-2. PubMed ID: 19694115
[TBL] [Abstract][Full Text] [Related]
14. Referral patterns and adjuvant chemotherapy use in patients with stage II colon cancer.
Kirkpatrick HM; Aitelli CL; Qin H; Becerra C; Lichliter WE; McCollum AD
Clin Colorectal Cancer; 2010 Jul; 9(3):150-6. PubMed ID: 20643619
[TBL] [Abstract][Full Text] [Related]
15. Adjuvant chemotherapy for stage II colon cancer: influence of care structures' characteristics on a controversial clinical practice.
Alter E; Phelip JM; Guilhot JN; Matysiak M; Vermorel M; Roblin X
Eur J Gastroenterol Hepatol; 2007 Nov; 19(11):995-1001. PubMed ID: 18049170
[TBL] [Abstract][Full Text] [Related]
16. Determining the Optimal Timing for Initiation of Adjuvant Chemotherapy After Resection for Stage II and III Colon Cancer.
Sun Z; Adam MA; Kim J; Nussbaum DP; Benrashid E; Mantyh CR; Migaly J
Dis Colon Rectum; 2016 Feb; 59(2):87-93. PubMed ID: 26734965
[TBL] [Abstract][Full Text] [Related]
17. Effect of age on survival benefit of adjuvant chemotherapy in elderly patients with Stage III colon cancer.
Zuckerman IH; Rapp T; Onukwugha E; Davidoff A; Choti MA; Gardner J; Seal B; Mullins CD
J Am Geriatr Soc; 2009 Aug; 57(8):1403-10. PubMed ID: 19563521
[TBL] [Abstract][Full Text] [Related]
18. Opportunity lost: Adjuvant chemotherapy in patients with stage III colon cancer remains underused.
Becerra AZ; Probst CP; Tejani MA; Aquina CT; González MG; Hensley BJ; Noyes K; Monson JR; Fleming FJ
Surgery; 2015 Sep; 158(3):692-9. PubMed ID: 26032822
[TBL] [Abstract][Full Text] [Related]
19. Final results of a randomised phase III study on adjuvant chemotherapy with 5 FU and levamisol in colon and rectum cancer stage II and III by the Norwegian Gastrointestinal Cancer Group.
Dahl O; Fluge Ø; Carlsen E; Wiig JN; Myrvold HE; Vonen B; Podhorny N; Bjerkeset O; Eide TJ; Halvorsen TB; Tveit KM;
Acta Oncol; 2009; 48(3):368-76. PubMed ID: 19242829
[TBL] [Abstract][Full Text] [Related]
20. Impact of patient age and comorbidity on surgeon versus oncologist preferences for adjuvant chemotherapy for stage III colon cancer.
Krzyzanowska MK; Regan MM; Powell M; Earle CC; Weeks JC
J Am Coll Surg; 2009 Feb; 208(2):202-9. PubMed ID: 19228531
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
